EV Biologics, Inc. (YECO)
EV Biologics, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Cheyenne, WY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,890. On trailing twelve-month figures it carries a trailing P/E of -0.05, a net margin of -158.1%. Its beta of 0.47 implies it has historically moved less than the broad market.
EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its proprietary, versatile EV platform to engineer innovative vaccines, treatments, and potential cures. Beyond EVs, it also dedicates efforts to cultivating human mesenchymal and other stem cells, as well as various cell-derived products, to address the needs of the cosmetic and biopharmaceutical industries. Founded in 2011, the firm was originally known as Yulong Eco-Materials Limited until its rebranding to EV Biologics, Inc. in August 2020, and it operates from its headquarters in Cheyenne, Wyoming.
EV Biologics, Inc. is most often compared with the following Healthcare names: